Executive summary of quality assurance (QA) visit to Chelsea and Westminster Hospital NHS Foundation Trust held on 6 September 2018.
The findings in this report relate to the quality assurance (QA) visit of the Coventry and Warwickshire screening service held on 10 July 2018.
The findings in this report relate to the quality assurance visit of the South Yorkshire and Bassetlaw screening service held on 15 March 2018.
The findings in this report relate to the quality assurance (QA) visit of the Essex screening service held on 20 February 2018.
Cardiovascular disease (CVD) prevention is a major public health priority in England. The NHS RightCare Optimal Pathway has highlighted 6 CVD high-risk conditions that are currently under-diagnosed and insufficiently managed despite a range of available interventions, and therefore represent targets
The findings in this report relate to the quality assurance (QA) visit of the Sussex AAA screening programme held on 22 February 2018.
Getting serious about cardiovascular disease in the south-west collects available data and evidence. This helps to target CVD prevention work along the care pathway. The report: identifies the gap in care and quality in the CVD pathway in the south-west summarises the CVD prevention initiatives already
Cardiac rehabilitation in the south-west reviews 2016 to 2017 data from the National Audit of Cardiac Rehabilitation to: highlight unmet need and gaps in care in relation to national standards summarise the opportunities for quality improvement provide recommendations addressing the
This guideline provides evidence-based recommendations for the management of cardiac arrest and the arrhythmias associated with acute coronary syndrome (ACS), chronic CHD and cardiac surgery. It excludes arrhythmias not associated with CHD such as supraventricular tachycardias associated with accessory pathways
Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta. This guidance has been updated to include a review of the cost model using more recent values. New evidence and updated costs identified
This report assesses cardiovascular disease in the South West. It focuses on risk factors, heart disease, stroke, kidney disease and diabetes. It is aimed at commissioners and providers of health care services in the South West. It collects available data and evidence,
This updated quality standard covers assessing, diagnosing and managing chronic heart failure in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.
This guideline provides evidence-based recommendations and best practice guidance on the management of patients with stable angina. It covers the investigations necessary to confirm the presence of stable angina, the optimum medical treatment to relieve symptoms and the relative benefits
Evidence-based recommendations on leadless cardiac pacemaker implantation for bradyarrhythmias in adults. This involves inserting a device into the heart that helps it beat at a normal rate. Evidence on the safety of leadless cardiac pacemaker implantation for bradyarrhythmias shows that
Evidence-based recommendations on sutureless aortic valve replacement for aortic stenosis in adults. This involves removing the narrowed aortic valve and replacing it with an artificial valve that holds itself in place. This guidance replaces NICE interventional procedures guidance on sutureless
The findings in this report relate to the quality assurance (QA) visit of the Lincolnshire AAA screening service held on 25 January 2018. The QA visit team identified 4 high priority findings as summarised below: The role of ultrasound lead
This guide provides further information on the recently updated NICE Guideline (CG71) Familial Hypercholesterolaemia: identification and management. It includes: a summary of recommendations from the recent update of the document an outline of national and European policy documents best practice case
The technologies described in this briefing are remote electrocardiogram (ECG) interpretation consultancy services. They are used for assisting in diagnosing and decision-making for people with cardiovascular disease. The innovative aspects are that with remote ECG interpretation, a person does not need to travel